Recent statewide poll indicates majority backing for an $8.4 billion bond focused on immunology and immunotherapy research, offering Californians optimism for novel treatments and potential cures
A clear majority of likely voters are in favor of voting YES on Prop 38, which aims to accelerate immunology and immunotherapy research leading to new treatments and revolutionary cures, ultimately saving more lives.”— Robin Swanson, spokesperson for YES on Proposition 38SACRAMENTO, CA, UNITED STATES, September 16, 2026 /EINPresswire.com/ — A recently published Public Policy Institute of California (PPIC) statewide survey* reveals that 55 percent of likely voters support Proposition 38, known as the Immunology Medical Research & Cures Initiative, which seeks to advance life-saving medical research.
Prop 38 aims to allocate $8.4 billion in essential funding to drive forward groundbreaking immunology medical research, with the goal of preventing and treating cancer, heart disease, Alzheimer’s, and other chronic and severe conditions that touch nearly every family in California.
The PPIC Californians and Their Government survey, conducted from September 4–10, 2026, assessed voter opinions on the upcoming November election, legislative measures, citizen initiatives, and both state and national matters.
“California voters recognize the enormous stakes for patients and families dealing with serious illnesses,” stated Robin Swanson, spokesperson for YES on Proposition 38. “Amid federal funding cuts for vital research that are causing delays in scientific and medical progress, this poll demonstrates that a strong majority of likely voters support YES on Prop 38 to further immunology and immunotherapy research, which will result in treatments and breakthrough cures, ultimately saving more lives.”
*Source: PPIC Statewide Survey, September 2026. The survey was conducted from September 4–10, 2026 (n=1,745 adults and n=1,103 likely voters).
Robin Swanson
Swanson Communications
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X
Other
